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Abstract
Tourette syndrome is a neurodevelopmental disorder characterized by tics and comorbid behavioral problems. This study
compared child- and parent-reported quality of life and everyday functioning. We assessed 75 children with Tourette syndrome,
of which 42 (56%) had comorbid conditions (obsessive-compulsive disorder ¼ 25; attention-deficit hyperactivity disorder ¼ 6;
both comorbidities ¼ 4). All patients completed psychometric instruments, including the Gilles de la Tourette Syndrome–Quality
of Life Scale for Children and Adolescents (child report) and the Child Tourette’s Syndrome Impairment Scale (parent report).
Data were compared for patients with pure Tourette syndrome, Tourette syndrome þ obsessive-compulsive disorder, Tourette
syndrome þ attention-deficit hyperactivity disorder, and Tourette syndrome þ both comorbidities. There were no group differ-
ences in quality of life. However, there were differences for total, school, and home activities impairment scores. Children and
parents may not share similar views about the impact of Tourette syndrome on functioning. The measurement of health-related
quality of life in Tourette syndrome is more complex in children than adults.
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Tourette syndrome is a childhood-onset neurodevelopmental
condition characterized by multiple motor tics and at least 1
vocal/phonic tic. Tics are rapid, recurrent, nonrhythmic, and
stereotyped movements/vocalizations that can be simple or
complex, are usually suggestible, and may be preceded by
premonitory urges and suppressed voluntarily. Although preva-
lence rates show wide variability, most recent studies suggest a
prevalence in youngsters aged 5 to 18 of about 1%, with a
male-female ratio of 4:1.
1
Tourette syndrome is a complex disorder. In 90% of cases,
additional behavioral problems are present (full-blown Tour-
ette syndrome and Tourette syndrome–plus). The spectrum of
behavioral difficulties ranges from complex tic-like symptoms
(self-injurious behaviors; non-obscene socially inappropriate
behaviors; and coprophenomena, echophenomena, and
paliphenomena) to symptoms of attention-deficit hyperactivity
disorder (ADHD), obsessive-compulsive disorder, mood disor-
ders, impulse control disorders, and personality disorders.
1
The presence of these comorbidities has been shown to be
associated with social difficulties and impulse dyscontrol in
young patients. Both tics and comorbid disorders associated
with Tourette syndrome are potentially socially disabling,
with the latter sometimes exerting greater detrimental impact.
2
In recent years, health-related quality of life has begun to be
established as an essential measure of clinical outcome, as it
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jcn.sagepub.comtakes into account the patient’s own subjective perspective.
The first disease-specific health-related quality of life assess-
ment tool for youths with Tourette syndrome was recently
developed and validated: the Gilles de la Tourette Syndrome–
Quality of Life Scale for Children and Adolescents.
3
In the clinical assessment of young patients with Tourette
syndrome, both self- and proxy report instruments are routinely
used to assist the specialist. These instruments allow thorough
investigation of the clinical characteristics of Tourette syn-
drome patients, and in particular, an assessment of comorbid
conditions. However, few previous studies have investigated
the usefulness of generic parent or self-report health-related
quality of life measures in complementing data obtained from
neuropsychiatric assessments and clinician-rated scales in
young Tourette syndrome patients.
2,4
The current study explored the functional impact of tics and
comorbid conditions among children and adolescents with
Tourette syndrome on health-related quality of life, comparing
both parent and child perceptions of well-being, using disease-
specific questionnaires.
Methods
Over the period 2009-2010, all consecutive outpatients with Tourette
syndrome seen at 3 specialist centers in Italy (the Child and Adoles-
cent Neuropsychiatry Unit at the University of Insubria, Varese; the
Department of Child Neuropsychiatry at the University of Catania;
and the Department of Child Neuropsychiatry at the University of
Rome) were invited to participate in the study. The study was
approved by the local Ethics Committee and written informed consent
was obtained from all subjects prior to enrolment.
All patients underwent neurologic examination, cognitive assess-
ment, and instrumental analysis (electroencephalography, brain
magnetic resonance imaging [MRI], standard laboratory test) to rule
out secondary tics and tourettism. We also excluded subjects with
learning disabilities (Intelligence Quotient <70) or other neurologic
conditions.
The 75 young patients recruited met Diagnostic and Statistical
Manual for Mental Disorders (4th edition, text revised) criteria
for Tourette syndrome (Varese: n ¼ 21; Rome: n ¼ 24; Catania:
n ¼ 30). All participants were clinically evaluated by a neuropsychia-
trist with substantial experience in Tourette syndrome. The clinical
interview included the National Hospital Interview Schedule for
Gilles de la Tourette syndrome, a detailed semi-structured interview
schedule,
5 and the Diagnostic Confidence Index, which rates the life-
time likelihood of having Tourette syndrome.
6 The Schedule for
Affective Disorders and Schizophrenia for School-Age Children–
Present and Lifetime Version
7 (a semistructured diagnostic interview
designed to assess current and past episodes of psychopathology in
children and adolescents according to Diagnostic and Statistical
Manual for Mental Disorders [3rd and 4th edition, text revised]
criteria) was used to validate the diagnosis of various Tourette
syndrome–associated disorders, such as ADHD and obsessive-
compulsive disorder. Tic severity was assessed using the Yale Global
Tic Severity Scale,
8 whereas the severity of obsessive-compulsive
symptoms was rated using the Children’s Yale-Brown Obsessive
Compulsive Scale.
9
All participants completed a standardized psychometric battery,
including the following self-report scales:
The Gilles de la Tourette Syndrome-Quality of Life Scale for
Children and Adolescents: a 27-item scale (Italian version) con-
sisting of 4 subscales (psychological, physical, obsessive-
compulsive and cognitive) in 2 age-adjusted versions: (1) an
interview to be administered by a qualified clinician for children
aged 6-12 years and (2) a self-report questionnaire for adoles-
cents aged 13-18 years.
3
The Child Depression Inventory: a 27-item self-report instrument
that assesses depressive symptoms in 7- to 17-year-olds.
10
The Multidimensional Anxiety Scale for Children: a 39-item self-
report scale that robustly represents the factor structure of
anxiety in children aged 8 to 18 years.
11
Child Tourette’s Syndrome Impairment Scale, a 37-item parent-
rated instrument covering school, home, and social activities
that may be impaired by tics or comorbid problems (including
obsessive-compulsive symptoms, depression, anxiety, opposi-
tional/disruptive behavior, hyperactivity, and inattention).
12
We split the sample into 4 groups. These were pure Tourette syn-
drome without comorbid conditions (n ¼ 33), Tourette syndrome þ
obsessive-compulsive disorder (n ¼ 25), Tourette syndrome þ ADHD
(n ¼ 6), and Tourette syndrome þ obsessive-compulsive disorder þ
ADHD (n ¼ 11). These groups were compared using nonparametric
Kruskal-Wallis H tests for quantitative variables (age; mean ratings
on clinical measures; mean scale and subscale scores), and chi-
square analysis for qualitative variables (sex; presence of tic-related
symptoms; pharmacotherapy). All statistical analyses were performed
using SPSS for Macintosh, version 18.0.2.
Results
We recruited 75 patients fulfilling diagnostic criteria for
Tourette syndrome (60 males; age range 6.8-18.3; mean +
SD ¼ 12.4 + 3.2 years; mean age of disease onset ¼ 6.7 +
2.4 years; mean disease duration ¼ 2.0 + 2.0 years). This sam-
ple was characterized by marked tic severity (Yale Global Tic
Severity Scale total score mean ¼ 44.3 + 20.5).
Demographic and clinical characteristics for the 4 groups
(pure Tourette syndrome ¼ 44%, Tourette syndrome þ
obsessive-compulsive disorder ¼ 33.3%, Tourette syndrome
þ ADHD ¼ 8%, Tourette syndrome þ obsessive-compulsive
disorder þ attention-deficit hyperactivity disorder ¼ 14.7%)
are summarized in Table 1. The Tourette syndrome þ
obsessive-compulsive disorder group was significantly older
than the other groups (P ¼ .014) and had higher Children’s
Yale-Brown Obsessive-Compulsive Scale scores (P < .001).
The Tourette syndrome þ ADHD group showed higher total tic
severity scores than the other 3 groups (P ¼ .008). There were
further differences between the groups for disease duration.
Table 2 shows the scores obtained from each group for the
quality of life scale and impairment scale. The comparison
between the 4 groups did not reveal any significant difference
inGillesdelaTourettesyndrome–qualityoflife,childandadoles-
cent version, total and subscale scores. However, when we com-
pared data obtained from the impairment scale across the 4
groups, we found significant differences for total (P ¼ .012),
schoolactivities(P¼.001),andhomeactivities(P¼.004)scores.
No differences were found for the social activities subscale.
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In this study, we examined the impact of tics and comorbid con-
ditionsonthehealth-relatedqualityoflifeofchildrenandadoles-
cents with Tourette syndrome, using parent report on the Child
Tourette’s Syndrome Impairment Scale and child report on the
Gilles de la Tourette Syndrome–Quality of Life Scale for Chil-
drenandAdolescents.Thesampleformed4subgroups,according
tothe presence(Tourettesyndromeþ obsessive-compulsivedis-
order; Tourette syndrome þ ADHD; Tourette syndrome þ
obsessive-compulsivedisorderþADHD)orabsence(pureTour-
ette syndrome) of comorbid conditions. There were differences
between the 4 groups for the severity of obsessive-compulsive
symptoms, as would be expected. Of greater interest, we found
that group with comorbid ADHD exhibited greater tic severity
than the pure Tourette syndrome and Tourette syndrome þ
obsessive-compulsive disorder groups, as reported by previous
studies.
13Despite this,we found nodifferences betweenthe sub-
groupsforthequalityoflifephysicalsubscale,whichshouldhave
been sensitive to the influence of tic severity.
14 However, other
studies have shown that tic severity is not always related to the
presenceofcomorbidconditions,
15thoughourfindingcouldhave
been affected by the small number of patients with Tourette syn-
drome þ ADHD.
We found significant differences between the 4 Tourette
syndrome subgroups for the Child Tourette Syndrome Impair-
ment Scale, which is consistent with prior research
4 using
generic instruments. Eddy et al.
2 found that comorbidity sub-
groups could be differentiated using a generic health-related
quality of life measure. The quality of life scale used in the
Table 2. Total and subscales scores of the Gilles de la Tourette Syndrome–Quality of Life Scale for Children and Adolescents and Child
Tourette’s Syndrome Impairment Scale.
Pure TS
(n ¼ 33)
TS þ OCD
(n ¼ 25)
TS þ ADHD
(n ¼ 6)
TS þ OCD þ ADHD
(n ¼ 11) P
Completed by children
Mean GTS-QOL-C&A total score (SD) 22.56 (15.27) 30.33 (22.35) 31.17 (11.69) 27.82 (16.52) .443
Mean GTS-QOL-C&A psychological score (SD) 9.88 (8.22) 13.64 (10.79) 15.67 (7.23) 10.73 (6.93) .346
Mean GTS-QOL-C&A physical/ADL score(SD) 5.66 (4.16) 6.17 (5.68) 6.17 (3.31) 7.00 (4.07) .719
Mean GTS-QOL-C&A obsessive-compulsive score(SD) 3.52 (3.40) 5.76 (4.25) 4.67 (3.08) 6.27 (3.88) .077
Mean GTS-QOL-C&A cognitive score (SD) 3.91 (2.49) 4.36 (3.79) 4.67 (2.73) 3.82 (3.68) .898
Mean GTS-QOL-C&A VAS score (SD) 77.58 (22.40) 67.58 (26.44) 61.67 (34.30) 72.27 (30.77) .384
Completed by parents
Mean CTIM-P total score (SD) 8.29 (12.10) 11.60 (15.80) 18.83 (16.49) 34.00 (25.23) .012
Mean CTIM-P school activities score (SD) 3.42 (4.32) 3.40 (4.81) 8.33 (5.85) 12.70 (7.88) .001
Mean CTIM-P home activities score (SD) 1.16 (2.76) 2.44 (4.59) 3.33 (4.50) 6.82 (6.48) .004
Mean CTIM-P social activities score (SD) 3.34 (6.46) 5.76 (9.31) 7.17 (9.70) 13.80 (14.31) .161
Abbreviations: ADHD, attention-deficit hyperactivity disorder; ADL, activities of daily living; CTIM-P, Child Tourette’s Syndrome Impairment Scale; GTS-QOL-
C&A, Gilles de la Tourette Syndrome–Quality of Life Scale for Children and Adolescents; OCD, obsessive-compulsive disorder; TS, Tourette syndrome; VAS,
Visual Analog Scale.
Note: Significant differences in bold.
Table 1. Demographic and Clinical Characteristics of the Tourette Syndrome Sample.
Pure TS
(n ¼ 33)
TS þ OCD
(n ¼ 25)
TS þ ADHD
(n ¼ 6)
TS þ OCD þ ADHD
(n ¼ 11) P
Male, n (%) 26 (78.8) 22 (88.0) 5 (83.3) 7 (63.6) .405
Age (y), mean (SD) 11.4 (2.8) 13.8 (3.4) 10.6 (2.4) 13.7 (3.1) .014
Age at onset of tics (y), mean (SD) 6.9 (2.2) 6.7 (2.6) 6.3 (3.2) 6.2 (2.3) .656
Disease duration (y), mean (SD) 1.4 (1.7) 2.7 (2.1) 1.1 (1.8) 2.9 (2.2) .011
DCI total score, mean (SD) 80 (23.4) 88.7 (25.1) 92.2 (19.6) 92.2 (23.5) .330
YGTSS global severity score, mean (SD) 35.8 (17.9) 48.2 (21.3) 56.3 (13.4) 54.5 (20.7) .008
YGTSS total motor tic score, mean (SD) 11.3 (4.6) 14.0 (6.3) 15.5 (3.5) 13.6 (5.5) .102
YGTSS total vocal tic score, mean (SD) 7.4 (5.3) 9.0 (5.6) 12.5 (4.6) 11.7 (6.1) .070
CY-BOCS total score, mean (SD) 4.9 (6.2) 18.3 (9.4) 7.3 (8.2) 17.5 (8.2) <.001
Tic-related symptoms, n (%) 10 (30.3) 12.0 (48.0) 4 (66.7) 7 (63.6) .130
CDI total score, mean (SD) 7.7 (5.1) 10.1 (7.4) 13.8 (6.7) 11.6 (9.2) .193
MASC total score, mean (SD) 49.1 (9.4) 49.4 (11.5) 53.3 (11.8) 49.3 (9.7) .803
Pharmacotherapy, n (%) 10 (30.3) 19 (76.0) 3 (50.0) 8 (72.7) .003
Abbreviations: ADHD, attention-deficit hyperactivity disorder; CDI, Child Depression Inventory; CY-BOCS, Children’s Yale-Brown Obsessive Compulsive Scale;
DCI, Diagnostic Confidence Index; MASC, Multidimensional Anxiety Scale for Children; OCD, obsessive-compulsive disorder; TS, Tourette syndrome; YGTSS,
Yale Global Tic Severity Scale.
Note: Significant differences in bold.
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4 patient groups. This finding is likely to reflect a strength in
the scale in focusing on core symptoms of Tourette syndrome
(eg, tics), which were shared by subgroups.
Significant differences were apparent when comparing child
self-report versus parent report of health-related quality of life.
These results suggest that children and parents may be unlikely
to share similar views about the overall functional impact of
Tourette syndrome. There are several potential explanations for
these findings. First, parents may place most emphasis on
comorbid conditions, which they perceive to be worse than tics,
leading to differences in the impairment scores across patient
subgroups. Children, however, may more readily notice the
impact of tics. Second, parent report of quality of life for
children with Tourette syndrome may be additionally influ-
enced by personal anxiety and feelings of responsibility that
concerned parents are likely to experience.
This study has some methodological limitations. The rela-
tively small number of patients limits the statistical power of
the analysis, and the small sample contained few patients with
Tourette syndrome þ ADHD. Two-thirds of the sample was
aged 6 to 11 years, and these young patients may have been less
aware of their difficulties. Finally, all patients were recruited
from specialist neuropsychiatric settings where more com-
plex/severe cases are seen, resulting in a sample characterized
by marked tic severity. Further studies addressing health-
related quality of life assessment in Tourette syndrome should
be carried out on larger samples and in community settings.
This study has demonstrated the utility of the Child Tour-
ette’s Syndrome Impairment Scale in differentiating between
subgroups of individuals with Tourette syndrome and comorbid
conditions.Perhapsmore important,we haveshownthere canbe
significant differences between health-related quality of life as
reported by young people with Tourette syndrome and their par-
ents. Future studies should therefore avoid relying exclusively
on parent report, as this may not constitute an accurate reflection
of the well-being of a young patient with Tourette syndrome.
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